ES2995203T3 - Analyte sensors featuring dual detection of glucose and ketones - Google Patents
Analyte sensors featuring dual detection of glucose and ketones Download PDFInfo
- Publication number
- ES2995203T3 ES2995203T3 ES20712075T ES20712075T ES2995203T3 ES 2995203 T3 ES2995203 T3 ES 2995203T3 ES 20712075 T ES20712075 T ES 20712075T ES 20712075 T ES20712075 T ES 20712075T ES 2995203 T3 ES2995203 T3 ES 2995203T3
- Authority
- ES
- Spain
- Prior art keywords
- active area
- membrane
- glucose
- sensitive active
- ketone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000012491 analyte Substances 0.000 title claims abstract description 235
- 150000002576 ketones Chemical class 0.000 title claims abstract description 186
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 title claims abstract description 161
- 239000008103 glucose Substances 0.000 title claims abstract description 161
- 238000001514 detection method Methods 0.000 title claims abstract description 48
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 title abstract description 27
- 230000009977 dual effect Effects 0.000 title abstract description 3
- 239000012528 membrane Substances 0.000 claims abstract description 171
- 102000004190 Enzymes Human genes 0.000 claims abstract description 76
- 108090000790 Enzymes Proteins 0.000 claims abstract description 76
- 239000000203 mixture Substances 0.000 claims abstract description 30
- 229920000642 polymer Polymers 0.000 claims description 98
- 229940088598 enzyme Drugs 0.000 claims description 73
- 239000012992 electron transfer agent Substances 0.000 claims description 36
- 101710088194 Dehydrogenase Proteins 0.000 claims description 26
- 238000004891 communication Methods 0.000 claims description 24
- 239000000758 substrate Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 23
- 229920002717 polyvinylpyridine Polymers 0.000 claims description 17
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 claims description 9
- 229950006238 nadide Drugs 0.000 claims description 8
- 230000035699 permeability Effects 0.000 claims description 8
- 238000003780 insertion Methods 0.000 claims description 6
- 230000037431 insertion Effects 0.000 claims description 6
- 108010015776 Glucose oxidase Proteins 0.000 claims description 4
- 239000004366 Glucose oxidase Substances 0.000 claims description 4
- 230000002255 enzymatic effect Effects 0.000 claims description 4
- 229940116332 glucose oxidase Drugs 0.000 claims description 4
- 235000019420 glucose oxidase Nutrition 0.000 claims description 4
- 108010050375 Glucose 1-Dehydrogenase Proteins 0.000 claims description 2
- 230000008569 process Effects 0.000 claims description 2
- 108090000854 Oxidoreductases Proteins 0.000 claims 1
- 102000004316 Oxidoreductases Human genes 0.000 claims 1
- 230000004962 physiological condition Effects 0.000 abstract description 6
- 230000002074 deregulated effect Effects 0.000 abstract 1
- 230000004044 response Effects 0.000 description 43
- 239000010410 layer Substances 0.000 description 33
- 230000033116 oxidation-reduction process Effects 0.000 description 29
- BAWFJGJZGIEFAR-NNYOXOHSSA-O NAD(+) Chemical compound NC(=O)C1=CC=C[N+]([C@H]2[C@@H]([C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]3[C@H]([C@@H](O)[C@@H](O3)N3C4=NC=NC(N)=C4N=C3)O)O2)O)=C1 BAWFJGJZGIEFAR-NNYOXOHSSA-O 0.000 description 23
- 238000012544 monitoring process Methods 0.000 description 22
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 17
- 238000006911 enzymatic reaction Methods 0.000 description 16
- 239000003012 bilayer membrane Substances 0.000 description 15
- 238000000151 deposition Methods 0.000 description 15
- 239000011248 coating agent Substances 0.000 description 14
- 238000000576 coating method Methods 0.000 description 14
- 238000001727 in vivo Methods 0.000 description 13
- 230000008021 deposition Effects 0.000 description 12
- 230000006870 function Effects 0.000 description 12
- 239000012530 fluid Substances 0.000 description 11
- 239000000243 solution Substances 0.000 description 11
- -1 as depicted Substances 0.000 description 10
- 238000010586 diagram Methods 0.000 description 10
- 210000001519 tissue Anatomy 0.000 description 10
- 230000001965 increasing effect Effects 0.000 description 9
- 230000000007 visual effect Effects 0.000 description 9
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 238000013459 approach Methods 0.000 description 8
- 229910052799 carbon Inorganic materials 0.000 description 8
- 239000002041 carbon nanotube Substances 0.000 description 8
- 229910021393 carbon nanotube Inorganic materials 0.000 description 8
- 230000000875 corresponding effect Effects 0.000 description 8
- 238000003618 dip coating Methods 0.000 description 8
- BOPGDPNILDQYTO-NNYOXOHSSA-N nicotinamide-adenine dinucleotide Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 BOPGDPNILDQYTO-NNYOXOHSSA-N 0.000 description 8
- 230000008901 benefit Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- 210000001124 body fluid Anatomy 0.000 description 6
- 230000006735 deficit Effects 0.000 description 6
- 230000008482 dysregulation Effects 0.000 description 6
- 230000036541 health Effects 0.000 description 6
- 239000003446 ligand Substances 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 239000008280 blood Substances 0.000 description 5
- 229920001577 copolymer Polymers 0.000 description 5
- 206010012601 diabetes mellitus Diseases 0.000 description 5
- 238000009792 diffusion process Methods 0.000 description 5
- 239000004205 dimethyl polysiloxane Substances 0.000 description 5
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 5
- 230000035945 sensitivity Effects 0.000 description 5
- KCALAFIVPCAXJI-UHFFFAOYSA-N 1,10-phenanthroline-5,6-dione Chemical compound C1=CC=C2C(=O)C(=O)C3=CC=CN=C3C2=N1 KCALAFIVPCAXJI-UHFFFAOYSA-N 0.000 description 4
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 4
- 239000008199 coating composition Substances 0.000 description 4
- 230000002153 concerted effect Effects 0.000 description 4
- 239000003431 cross linking reagent Substances 0.000 description 4
- 239000003989 dielectric material Substances 0.000 description 4
- 230000002500 effect on skin Effects 0.000 description 4
- 230000004907 flux Effects 0.000 description 4
- 125000000524 functional group Chemical group 0.000 description 4
- 239000008240 homogeneous mixture Substances 0.000 description 4
- 210000003491 skin Anatomy 0.000 description 4
- 108010007843 NADH oxidase Proteins 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- 229910021607 Silver chloride Inorganic materials 0.000 description 3
- 102000019197 Superoxide Dismutase Human genes 0.000 description 3
- 108010012715 Superoxide dismutase Proteins 0.000 description 3
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 239000002131 composite material Substances 0.000 description 3
- 230000002596 correlated effect Effects 0.000 description 3
- 238000003869 coulometry Methods 0.000 description 3
- 238000000835 electrochemical detection Methods 0.000 description 3
- 238000003487 electrochemical reaction Methods 0.000 description 3
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
- 230000001771 impaired effect Effects 0.000 description 3
- 235000020887 ketogenic diet Nutrition 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000006722 reduction reaction Methods 0.000 description 3
- 230000027756 respiratory electron transport chain Effects 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 229910052723 transition metal Inorganic materials 0.000 description 3
- 150000003624 transition metals Chemical class 0.000 description 3
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 2
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 102000028526 Dihydrolipoamide Dehydrogenase Human genes 0.000 description 2
- 108010028127 Dihydrolipoamide Dehydrogenase Proteins 0.000 description 2
- 239000007995 HEPES buffer Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- YRKCREAYFQTBPV-UHFFFAOYSA-N acetylacetone Chemical compound CC(=O)CC(C)=O YRKCREAYFQTBPV-UHFFFAOYSA-N 0.000 description 2
- 230000002457 bidirectional effect Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 238000011088 calibration curve Methods 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000003722 extracellular fluid Anatomy 0.000 description 2
- 239000000446 fuel Substances 0.000 description 2
- 229920001519 homopolymer Polymers 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000014759 maintenance of location Effects 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 238000012806 monitoring device Methods 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 229910052762 osmium Inorganic materials 0.000 description 2
- SYQBFIAQOQZEGI-UHFFFAOYSA-N osmium atom Chemical compound [Os] SYQBFIAQOQZEGI-UHFFFAOYSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229920002006 poly(N-vinylimidazole) polymer Polymers 0.000 description 2
- 239000012925 reference material Substances 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 239000003381 stabilizer Substances 0.000 description 2
- 238000007920 subcutaneous administration Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000001755 vocal effect Effects 0.000 description 2
- AOBIOSPNXBMOAT-UHFFFAOYSA-N 2-[2-(oxiran-2-ylmethoxy)ethoxymethyl]oxirane Chemical compound C1OC1COCCOCC1CO1 AOBIOSPNXBMOAT-UHFFFAOYSA-N 0.000 description 1
- HRPVXLWXLXDGHG-UHFFFAOYSA-N Acrylamide Chemical compound NC(=O)C=C HRPVXLWXLXDGHG-UHFFFAOYSA-N 0.000 description 1
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 description 1
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical compound N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 239000004971 Cross linker Substances 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- BRLQWZUYTZBJKN-UHFFFAOYSA-N Epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010023379 Ketoacidosis Diseases 0.000 description 1
- 208000007976 Ketosis Diseases 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 101100388055 Mus musculus Polm gene Proteins 0.000 description 1
- NQTADLQHYWFPDB-UHFFFAOYSA-N N-Hydroxysuccinimide Chemical compound ON1C(=O)CCC1=O NQTADLQHYWFPDB-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- KJTLSVCANCCWHF-UHFFFAOYSA-N Ruthenium Chemical compound [Ru] KJTLSVCANCCWHF-UHFFFAOYSA-N 0.000 description 1
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical compound [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 1
- 208000003443 Unconsciousness Diseases 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- CLWRFNUKIFTVHQ-UHFFFAOYSA-N [N].C1=CC=NC=C1 Chemical group [N].C1=CC=NC=C1 CLWRFNUKIFTVHQ-UHFFFAOYSA-N 0.000 description 1
- GELXFVQAWNTGPQ-UHFFFAOYSA-N [N].C1=CNC=N1 Chemical group [N].C1=CNC=N1 GELXFVQAWNTGPQ-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- 210000004381 amniotic fluid Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 239000013060 biological fluid Substances 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 230000000981 bystander Effects 0.000 description 1
- 229940075397 calomel Drugs 0.000 description 1
- 239000003990 capacitor Substances 0.000 description 1
- 150000001718 carbodiimides Chemical class 0.000 description 1
- 125000002843 carboxylic acid group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 239000004020 conductor Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 150000004696 coordination complex Chemical class 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- MGNCLNQXLYJVJD-UHFFFAOYSA-N cyanuric chloride Chemical compound ClC1=NC(Cl)=NC(Cl)=N1 MGNCLNQXLYJVJD-UHFFFAOYSA-N 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000003111 delayed effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- ZOMNIUBKTOKEHS-UHFFFAOYSA-L dimercury dichloride Chemical compound Cl[Hg][Hg]Cl ZOMNIUBKTOKEHS-UHFFFAOYSA-L 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229910021389 graphene Inorganic materials 0.000 description 1
- 231100001261 hazardous Toxicity 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- 150000002463 imidates Chemical class 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 239000012212 insulator Substances 0.000 description 1
- 230000035987 intoxication Effects 0.000 description 1
- 231100000566 intoxication Toxicity 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- UETZVSHORCDDTH-UHFFFAOYSA-N iron(2+);hexacyanide Chemical compound [Fe+2].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-].N#[C-] UETZVSHORCDDTH-UHFFFAOYSA-N 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 150000002736 metal compounds Chemical class 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- FQPSGWSUVKBHSU-UHFFFAOYSA-N methacrylamide Chemical compound CC(=C)C(N)=O FQPSGWSUVKBHSU-UHFFFAOYSA-N 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 150000002907 osmium Chemical class 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000000737 periodic effect Effects 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 229920000075 poly(4-vinylpyridine) Polymers 0.000 description 1
- 229920000647 polyepoxide Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 238000006479 redox reaction Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 229910052707 ruthenium Inorganic materials 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 210000001179 synovial fluid Anatomy 0.000 description 1
- 230000004580 weight loss Effects 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14532—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring glucose, e.g. by tissue impedance measurement
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/14546—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue for measuring analytes not otherwise provided for, e.g. ions, cytochromes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1468—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means
- A61B5/1486—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase
- A61B5/14865—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using chemical or electrochemical methods, e.g. by polarographic means using enzyme electrodes, e.g. with immobilised oxidase invasive, e.g. introduced into the body by a catheter or needle or using implanted sensors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/041—Mixtures of macromolecular compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Surgery (AREA)
- Pathology (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Optics & Photonics (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962797566P | 2019-01-28 | 2019-01-28 | |
| US201962884869P | 2019-08-09 | 2019-08-09 | |
| PCT/US2020/015365 WO2020159956A1 (en) | 2019-01-28 | 2020-01-28 | Analyte sensors and sensing methods featuring dual detection of glucose and ketones |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2995203T3 true ES2995203T3 (en) | 2025-02-07 |
Family
ID=69845516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES20712075T Active ES2995203T3 (en) | 2019-01-28 | 2020-01-28 | Analyte sensors featuring dual detection of glucose and ketones |
Country Status (13)
| Country | Link |
|---|---|
| US (9) | US12594013B2 (https=) |
| EP (5) | EP4574038A3 (https=) |
| JP (4) | JP7196315B2 (https=) |
| CN (1) | CN113329689A (https=) |
| AU (3) | AU2020216325B2 (https=) |
| CA (1) | CA3123053A1 (https=) |
| DK (1) | DK3917396T3 (https=) |
| ES (1) | ES2995203T3 (https=) |
| FI (1) | FI3917396T3 (https=) |
| LT (1) | LT3917396T (https=) |
| MX (2) | MX2021008964A (https=) |
| MY (1) | MY196781A (https=) |
| WO (1) | WO2020159956A1 (https=) |
Families Citing this family (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3423591T3 (da) | 2016-03-04 | 2024-01-29 | Abbott Diabetes Care Inc | NAD(P)-afhængige sensitive enzymer, elektroder og sensorer og fremgangsmåder til fremstilling og anvendelse deraf |
| EP4574038A3 (en) | 2019-01-28 | 2025-08-27 | Abbott Diabetes Care, Inc. | Analyte sensors and sensing methods featuring dual detection of glucose and ketones |
| CA3126240A1 (en) | 2019-01-28 | 2020-08-06 | Abbott Diabetes Cares Inc. | Analyte sensors employing multiple enzymes and methods associated therewith |
| CN113453620B (zh) | 2019-01-28 | 2024-03-05 | 美国雅培糖尿病护理公司 | 用于双重检测葡萄糖和乙醇的分析物传感器和感测方法 |
| CN115038381A (zh) | 2020-01-03 | 2022-09-09 | 美国雅培糖尿病护理公司 | 用于检测多种分析物的传感器阵列系统和方法 |
| JP7397222B2 (ja) | 2020-05-29 | 2023-12-12 | アボット ダイアベティス ケア インコーポレイテッド | ジアホラーゼの阻害剤を検出するための分析物センサおよびセンシング方法 |
| CA3181614A1 (en) | 2020-06-16 | 2021-12-23 | Abbott Diabetes Care Inc. | Analyte sensors featuring a reduced-area working electrode for decreasing interferent signal |
| EP4165400A4 (en) | 2020-06-16 | 2024-07-10 | Abbott Diabetes Care Inc. | ANALYTICAL SENSORS WITH WORKING ELECTRODE APERITY PLANING TO REDUCE INTERFERING SIGNALS |
| JP2023534645A (ja) | 2020-07-08 | 2023-08-10 | アボット ダイアベティス ケア インコーポレイテッド | 干渉信号を低減するための強化を特徴とする検体センサ |
| CN116829068A (zh) * | 2020-12-10 | 2023-09-29 | 美国雅培糖尿病护理公司 | 用于传感酮的分析物传感器和使用其的方法 |
| EP4258991A1 (en) * | 2020-12-10 | 2023-10-18 | Abbott Diabetes Care, Inc. | Analyte sensors for sensing ketones and methods of using the same |
| AU2021400588B2 (en) | 2020-12-15 | 2025-04-10 | Abbott Diabetes Care Inc. | Nad(p) depot for nad(p)-dependent enzyme-based sensors |
| AU2021410547B2 (en) | 2020-12-23 | 2025-12-18 | Abbott Diabetes Care Inc. | Analyte sensors with reduced interferent signal and methods |
| US20220192553A1 (en) * | 2020-12-23 | 2022-06-23 | Abbott Diabetes Care Inc. | Analyte sensors for sensing glutamate and methods of using the same |
| US12345671B2 (en) | 2020-12-30 | 2025-07-01 | Abbott Diabetes Care Inc. | Analyte sensors for detecting asparagine and aspartate and methods of use thereof |
| AU2022205038B2 (en) * | 2020-12-31 | 2025-12-04 | Abbott Diabetes Care Inc. | Analyte sensors and methods of use thereof |
| JP2024504174A (ja) * | 2021-01-26 | 2024-01-30 | アボット ダイアベティス ケア インコーポレイテッド | ケトンセンサに関連するシステム、デバイス、および方法 |
| US12226239B2 (en) | 2021-09-15 | 2025-02-18 | Lingo Sensing Technology Unlimited Company | Systems, devices, and methods for applications for communication with ketone sensors |
| US20240389890A1 (en) * | 2021-09-27 | 2024-11-28 | Medtrum Technologies Inc. | Analyte detection system |
| US12442786B2 (en) * | 2021-10-14 | 2025-10-14 | Medtronic Minimed, Inc. | Sensors for 3-hydroxybutyrate detection |
| US12527500B2 (en) * | 2021-12-02 | 2026-01-20 | Medtronic Minimed, Inc. | Ketone limiting membrane and dual layer membrane approach for ketone sensing |
| WO2024020007A1 (en) | 2022-07-19 | 2024-01-25 | Abbott Diabetes Care Inc. | Analyte sensors with reduced interferent signal and methods |
| EP4382611A1 (en) * | 2022-08-31 | 2024-06-12 | Medtronic MiniMed, Inc. | Sensors for 3-hydroxybutyrate detection |
| CA3272466A1 (en) * | 2022-12-23 | 2024-06-27 | Abbott Diabetes Care Inc. | ANALYTICAL MONITORING SYSTEMS AND METHODS |
| CN120201995A (zh) | 2022-12-30 | 2025-06-24 | 雅培糖尿病护理公司 | 药物递送组合物和控制皮下传感器的药物递送速率的方法 |
| JP2026501637A (ja) * | 2022-12-30 | 2026-01-16 | デックスコム・インコーポレーテッド | グルコース及びケトンのハイブリッド監視のための感知システム及び方法 |
| EP4655412A2 (en) | 2023-01-25 | 2025-12-03 | Abbott Diabetes Care, Inc. | Temperature-insensitive membranes for analyte sensors |
| CN121099950A (zh) | 2023-03-31 | 2025-12-09 | 雅培糖尿病护理公司 | 抗坏血酸盐阻断膜 |
| CN121174989A (zh) | 2023-05-24 | 2025-12-19 | 雅培糖尿病护理公司 | 用于将治疗剂结合到分析物传感器中的方法 |
| CN116735885B (zh) * | 2023-05-25 | 2025-02-11 | 深圳硅基传感科技有限公司 | 多分析物监测传感器 |
| WO2024249832A1 (en) * | 2023-06-01 | 2024-12-05 | The University Of North Carolina At Chapel Hill | R-3-hydroxybutyrate binding proteins (bhbbps) and their use for ketone monitoring |
| CN116718657A (zh) * | 2023-06-12 | 2023-09-08 | 深圳木芯科技有限公司 | 葡萄糖生物传感膜的制备方法及葡萄糖生物传感器 |
| CN121752187A (zh) * | 2023-09-22 | 2026-03-27 | 上海移宇科技有限公司 | 一种多基底结构增强型分析物传感器 |
| CN121843651A (zh) | 2023-09-22 | 2026-04-10 | 雅培糖尿病护理公司 | 葡萄糖-酮传感器的决策支持 |
| US20250194964A1 (en) | 2023-12-19 | 2025-06-19 | Abbott Diabetes Care, Inc. | Glucose oxidase sensors with improved stability |
Family Cites Families (161)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4321123A (en) | 1978-04-21 | 1982-03-23 | Matsushita Electric Industrial Co., Ltd. | Coenzyme immobilized electrode |
| GB2067764B (en) | 1980-01-09 | 1984-01-25 | Nat Res Dev | Transcutaneous gas sensor |
| US5682884A (en) | 1983-05-05 | 1997-11-04 | Medisense, Inc. | Strip electrode with screen printing |
| JPS6125541A (ja) * | 1984-07-16 | 1986-02-04 | 株式会社日立製作所 | 経皮グルコ−スセンサ |
| US4680268A (en) | 1985-09-18 | 1987-07-14 | Children's Hospital Medical Center | Implantable gas-containing biosensor and method for measuring an analyte such as glucose |
| US5262035A (en) | 1989-08-02 | 1993-11-16 | E. Heller And Company | Enzyme electrodes |
| US5264105A (en) | 1989-08-02 | 1993-11-23 | Gregg Brian A | Enzyme electrodes |
| US5593852A (en) | 1993-12-02 | 1997-01-14 | Heller; Adam | Subcutaneous glucose electrode |
| JPH04278450A (ja) | 1991-03-04 | 1992-10-05 | Adam Heller | バイオセンサー及び分析物を分析する方法 |
| US5322063A (en) | 1991-10-04 | 1994-06-21 | Eli Lilly And Company | Hydrophilic polyurethane membranes for electrochemical glucose sensors |
| US5965106A (en) | 1992-03-04 | 1999-10-12 | Perimmune Holdings, Inc. | In vivo binding pair pretargeting |
| DE4442253A1 (de) | 1994-11-28 | 1996-05-30 | Bayer Corp N D Ges D Staates I | Elektrochemischer Enzymbiosensor |
| US5792621A (en) | 1995-06-28 | 1998-08-11 | The United States Of America As Represented By The Administrator Of The National Aeronautics And Space Administration | Fiber-optic chemiluminescent biosensors for monitoring aqueous alcohols and other water quality parameters |
| US5696314A (en) | 1996-07-12 | 1997-12-09 | Chiron Diagnostics Corporation | Multilayer enzyme electrode membranes and methods of making same |
| US6071391A (en) | 1997-09-12 | 2000-06-06 | Nok Corporation | Enzyme electrode structure |
| US6736957B1 (en) | 1997-10-16 | 2004-05-18 | Abbott Laboratories | Biosensor electrode mediators for regeneration of cofactors and process for using |
| US6579690B1 (en) | 1997-12-05 | 2003-06-17 | Therasense, Inc. | Blood analyte monitoring through subcutaneous measurement |
| US6030827A (en) | 1998-01-23 | 2000-02-29 | I-Stat Corporation | Microfabricated aperture-based sensor |
| US6134461A (en) | 1998-03-04 | 2000-10-17 | E. Heller & Company | Electrochemical analyte |
| US6241863B1 (en) | 1998-04-27 | 2001-06-05 | Harold G. Monbouquette | Amperometric biosensors based on redox enzymes |
| US8688188B2 (en) | 1998-04-30 | 2014-04-01 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods of use |
| US6175752B1 (en) | 1998-04-30 | 2001-01-16 | Therasense, Inc. | Analyte monitoring device and methods of use |
| GB2337122B (en) | 1998-05-08 | 2002-11-13 | Medisense Inc | Test strip |
| US5965105A (en) | 1998-06-12 | 1999-10-12 | Council Of Scientific And Industrial Research | Process for the synthesis of flyash based Zeolite-A |
| US6294281B1 (en) | 1998-06-17 | 2001-09-25 | Therasense, Inc. | Biological fuel cell and method |
| US5902731A (en) | 1998-09-28 | 1999-05-11 | Lifescan, Inc. | Diagnostics based on tetrazolium compounds |
| US6338790B1 (en) * | 1998-10-08 | 2002-01-15 | Therasense, Inc. | Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| US6377894B1 (en) | 1998-11-30 | 2002-04-23 | Abbott Laboratories | Analyte test instrument having improved calibration and communication processes |
| EP1192269A2 (en) | 1999-06-18 | 2002-04-03 | Therasense, Inc. | MASS TRANSPORT LIMITED i IN VIVO /i ANALYTE SENSOR |
| US6514460B1 (en) | 1999-07-28 | 2003-02-04 | Abbott Laboratories | Luminous glucose monitoring device |
| DE60035123T2 (de) | 1999-11-15 | 2008-01-31 | Therasense, Inc., Alameda | Übergangsmetallkomplexe, die über ein bewegliches zwischenglied an ein polymer gebunden sind |
| US8444834B2 (en) | 1999-11-15 | 2013-05-21 | Abbott Diabetes Care Inc. | Redox polymers for use in analyte monitoring |
| US8268143B2 (en) | 1999-11-15 | 2012-09-18 | Abbott Diabetes Care Inc. | Oxygen-effect free analyte sensor |
| US6541216B1 (en) | 1999-12-22 | 2003-04-01 | Roche Diagnostics Corporation | Amperometric biosensor test strip |
| WO2001088524A1 (en) | 2000-05-12 | 2001-11-22 | Therasense, Inc. | Electrodes with multilayer membranes and methods of using and making the electrodes |
| US6560471B1 (en) | 2001-01-02 | 2003-05-06 | Therasense, Inc. | Analyte monitoring device and methods of use |
| US6676816B2 (en) | 2001-05-11 | 2004-01-13 | Therasense, Inc. | Transition metal complexes with (pyridyl)imidazole ligands and sensors using said complexes |
| US6932894B2 (en) | 2001-05-15 | 2005-08-23 | Therasense, Inc. | Biosensor membranes composed of polymers containing heterocyclic nitrogens |
| US6915147B2 (en) | 2001-09-07 | 2005-07-05 | Medtronic Minimed, Inc. | Sensing apparatus and process |
| US6984307B2 (en) | 2001-10-05 | 2006-01-10 | Stephen Eliot Zweig | Dual glucose-hydroxybutyrate analytical sensors |
| GB0130684D0 (en) | 2001-12-21 | 2002-02-06 | Oxford Biosensors Ltd | Micro-band electrode |
| US8364229B2 (en) | 2003-07-25 | 2013-01-29 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
| US6946299B2 (en) | 2002-04-25 | 2005-09-20 | Home Diagnostics, Inc. | Systems and methods for blood glucose sensing |
| US20040061232A1 (en) | 2002-09-27 | 2004-04-01 | Medtronic Minimed, Inc. | Multilayer substrate |
| US7501053B2 (en) | 2002-10-23 | 2009-03-10 | Abbott Laboratories | Biosensor having improved hematocrit and oxygen biases |
| US7811231B2 (en) | 2002-12-31 | 2010-10-12 | Abbott Diabetes Care Inc. | Continuous glucose monitoring system and methods of use |
| JP4839569B2 (ja) | 2003-06-05 | 2011-12-21 | ソニー株式会社 | 酵素固定化電極およびその製造方法ならびに電極反応利用装置およびその製造方法 |
| US7460898B2 (en) | 2003-12-05 | 2008-12-02 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US9763609B2 (en) | 2003-07-25 | 2017-09-19 | Dexcom, Inc. | Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise |
| WO2007120442A2 (en) | 2003-07-25 | 2007-10-25 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US20050067277A1 (en) | 2003-09-30 | 2005-03-31 | Pierce Robin D. | Low volume electrochemical biosensor |
| WO2005040404A1 (en) | 2003-10-29 | 2005-05-06 | Agency For Science, Technology And Research | Biosensor |
| US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
| US7577470B2 (en) | 2003-11-13 | 2009-08-18 | Medtronic Minimed, Inc. | Long term analyte sensor array |
| US8414489B2 (en) | 2003-11-13 | 2013-04-09 | Medtronic Minimed, Inc. | Fabrication of multi-sensor arrays |
| US8423114B2 (en) | 2006-10-04 | 2013-04-16 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| ATE480761T1 (de) | 2003-12-05 | 2010-09-15 | Dexcom Inc | Kalibrationsmethoden für einen kontinuierlich arbeitenden analytsensor |
| US8948836B2 (en) | 2003-12-26 | 2015-02-03 | Medtronic Minimed, Inc. | Implantable apparatus for sensing multiple parameters |
| US8165651B2 (en) | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
| US20070270672A1 (en) | 2004-08-31 | 2007-11-22 | Hayter Paul G | Wearable Sensor Device and System |
| US8211038B2 (en) | 2004-09-17 | 2012-07-03 | Abbott Diabetes Care Inc. | Multiple-biosensor article |
| US7545272B2 (en) | 2005-02-08 | 2009-06-09 | Therasense, Inc. | RF tag on test strips, test strip vials and boxes |
| US8060174B2 (en) | 2005-04-15 | 2011-11-15 | Dexcom, Inc. | Analyte sensing biointerface |
| US20070095661A1 (en) | 2005-10-31 | 2007-05-03 | Yi Wang | Method of making, and, analyte sensor |
| JP2007163268A (ja) | 2005-12-13 | 2007-06-28 | Canon Inc | 酵素電極 |
| AU2007221172A1 (en) * | 2006-02-27 | 2007-09-07 | Edwards Lifesciences Corporation | Flux limiting membrane for intravenous amperometric biosensor |
| JP4802842B2 (ja) | 2006-04-24 | 2011-10-26 | 株式会社デンソー | 健康管理支援装置及び健康管理システム |
| US9700252B2 (en) | 2006-06-19 | 2017-07-11 | Roche Diabetes Care, Inc. | Amperometric sensor and method for its manufacturing |
| WO2008041984A1 (en) | 2006-10-04 | 2008-04-10 | Dexcom, Inc. | Dual electrode system for a continuous analyte sensor |
| US7822557B2 (en) | 2006-10-31 | 2010-10-26 | Abbott Diabetes Care Inc. | Analyte sensors and methods |
| US8808515B2 (en) | 2007-01-31 | 2014-08-19 | Abbott Diabetes Care Inc. | Heterocyclic nitrogen containing polymers coated analyte monitoring device and methods of use |
| CA2690742C (en) | 2007-06-21 | 2018-05-15 | Abbott Diabetes Care Inc. | Health management devices and methods |
| PL2205964T3 (pl) | 2007-09-24 | 2015-12-31 | Bayer Healthcare Llc | Czujniki testowe, sposoby oraz systemy o wielu rejonach i potencjałach |
| US20100268043A1 (en) | 2007-11-07 | 2010-10-21 | Ofer Yodfat | Device and Method for Preventing Diabetic Complications |
| WO2009100082A1 (en) | 2008-02-04 | 2009-08-13 | Bayer Healthcare Llc | Semiconductor based analyte sensors and methods |
| WO2009105337A2 (en) | 2008-02-20 | 2009-08-27 | Dexcom, Inc. | Continuous medicament sensor system for in vivo use |
| JP2009245930A (ja) | 2008-03-12 | 2009-10-22 | Sony Corp | 燃料電池およびその製造方法ならびに酵素固定化電極およびその製造方法ならびに電子機器 |
| US20090247855A1 (en) * | 2008-03-28 | 2009-10-01 | Dexcom, Inc. | Polymer membranes for continuous analyte sensors |
| JP2009272179A (ja) | 2008-05-08 | 2009-11-19 | Sony Corp | 新規な酵素電極及び該酵素電極を用いた燃料電池 |
| WO2009139101A1 (ja) | 2008-05-13 | 2009-11-19 | パナソニック株式会社 | 電子機器システム、および半導体集積回路のコントローラ |
| US8620398B2 (en) * | 2008-06-02 | 2013-12-31 | Abbott Diabetes Care Inc. | Reference electrodes having an extended lifetime for use in long term amperometric sensors |
| WO2010027771A1 (en) * | 2008-08-27 | 2010-03-11 | Edwards Lifesciences Corporation | Analyte sensor |
| US8636884B2 (en) | 2008-09-15 | 2014-01-28 | Abbott Diabetes Care Inc. | Cationic polymer based wired enzyme formulations for use in analyte sensors |
| WO2010041511A1 (ja) | 2008-10-06 | 2010-04-15 | ソニー株式会社 | 燃料電池および酵素電極 |
| US20100198034A1 (en) | 2009-02-03 | 2010-08-05 | Abbott Diabetes Care Inc. | Compact On-Body Physiological Monitoring Devices and Methods Thereof |
| FI3912551T3 (fi) | 2009-02-26 | 2023-10-31 | Abbott Diabetes Care Inc | Parannettuja analyyttiantureita ja menetelmiä niiden valmistamiseksi ja käyttämiseksi |
| US20100213057A1 (en) | 2009-02-26 | 2010-08-26 | Benjamin Feldman | Self-Powered Analyte Sensor |
| EP2448478A4 (en) | 2009-06-30 | 2014-03-12 | Abbott Diabetes Care Inc | EXTRUDED ELECTRODE STRUCTURES, AND METHODS OF USE |
| US20100331643A1 (en) | 2009-06-30 | 2010-12-30 | Abbott Diabetes Care Inc. | Extruded Analyte Sensors and Methods of Using Same |
| US9351677B2 (en) | 2009-07-02 | 2016-05-31 | Dexcom, Inc. | Analyte sensor with increased reference capacity |
| EP2473963A4 (en) | 2009-08-31 | 2014-01-08 | Abbott Diabetes Care Inc | MEDICAL DEVICES AND METHOD |
| US20110048972A1 (en) | 2009-08-31 | 2011-03-03 | Lifescan Scotland Limited | Multi-analyte test strip with shared counter/reference electrode and inline electrode configuration |
| EP2473847B1 (en) * | 2009-09-04 | 2016-08-24 | Lifescan Scotland Limited | Glucose measurement method and system |
| WO2011031675A1 (en) | 2009-09-08 | 2011-03-17 | Abbott Diabetes Care Inc. | Methods and articles of manufacture for hosting a safety critical application on an uncontrolled data processing device |
| US20120181189A1 (en) | 2009-09-24 | 2012-07-19 | Fresenius Medical Care Holdings, Inc. | Amperometric Creatinine Biosensor With Immobilized Enzyme-Polymer Composition And Systems Using Same, And Methods |
| US8545693B2 (en) * | 2009-09-29 | 2013-10-01 | Lifescan Scotland Limited | Analyte measurment method and system |
| US8323467B2 (en) | 2009-10-27 | 2012-12-04 | Lifescan Scotland Limited | Dual chamber, multi-analyte test strip with opposing electrodes |
| US20120283537A1 (en) | 2009-10-30 | 2012-11-08 | Petisce James R | Analyte sensor layers and methods related thereto |
| US8354013B2 (en) | 2009-11-24 | 2013-01-15 | Abbott Diabetes Care Inc. | Analyte sensors comprising high-boiling point solvents |
| US9042954B2 (en) | 2009-11-24 | 2015-05-26 | Abbott Diabetes Care Inc. | Analyte sensors comprising hydrogel membranes |
| US20110124993A1 (en) | 2009-11-24 | 2011-05-26 | Abbott Diabetes Care Inc. | Analyte Sensors Comprising Self-Polymerizing Hydrogels |
| JP5551419B2 (ja) | 2009-11-27 | 2014-07-16 | 株式会社イノアックコーポレーション | ダクト |
| US8497359B2 (en) | 2010-02-26 | 2013-07-30 | Ppg Industries Ohio, Inc. | Cationic electrodepositable coating composition comprising lignin |
| US20110256024A1 (en) | 2010-04-16 | 2011-10-20 | Abbott Diabetes Care Inc. | Modular Analyte Monitoring Device |
| AU2011239548A1 (en) | 2010-04-16 | 2012-01-19 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
| JP5423580B2 (ja) | 2010-05-17 | 2014-02-19 | トヨタ自動車株式会社 | 酵素電極およびそれを備えるバイオ燃料電池 |
| US9402574B2 (en) | 2010-06-25 | 2016-08-02 | The University Of Connecticut | Sensors for analyte detection and methods of manufacture thereof |
| DK2598021T3 (da) | 2010-07-28 | 2015-09-28 | Abbott Diabetes Care Inc | Analytsensorer med temperaturuafhængige membraner |
| EP2608715B1 (en) * | 2010-08-24 | 2016-06-22 | Microchips, Inc. | Implantable biosensor device and methods of use thereof |
| WO2012068393A1 (en) | 2010-11-18 | 2012-05-24 | Abbott Diabetes Care Inc. | Adaptor for on-body analyte monitoring system |
| US9468402B2 (en) | 2010-12-01 | 2016-10-18 | Pinnacle Technology, Inc. | Tissue implantable microbiosensor |
| US20120138484A1 (en) | 2010-12-03 | 2012-06-07 | Abbott Diabetes Care Inc. | Analyte Sensors Comprising Thickeners, Enzyme Stabilizers and Osmium Boronates |
| FI3954781T3 (fi) | 2010-12-09 | 2024-10-08 | Abbott Diabetes Care Inc | Analyyttiantureita, joissa on havaintopinta, jossa on pieniä havaintopisteitä |
| US8608921B2 (en) | 2011-01-20 | 2013-12-17 | Medtronic Minimed, Inc. | Layered enzyme compositions for use with analyte sensors |
| CA3277222A1 (en) | 2011-02-28 | 2025-10-30 | Abbott Diabetes Care Inc. | Devices, systems, and methods associated with analyte monitoring devices and devices incorporating the same |
| US9380965B2 (en) | 2011-05-20 | 2016-07-05 | Abbott Diabetes Care Inc. | Analyte sensors having a membrane with low temperature sensitivity |
| FI2720610T3 (fi) | 2011-06-17 | 2025-09-30 | Abbott Diabetes Care Inc | Pinottu analyyttianturi, jonka ensimmäinen elektrodi on kapeampi kuin anturin toinen elektrodi |
| EP3677182B1 (en) | 2011-11-07 | 2022-05-04 | Abbott Diabetes Care Inc. | Analyte monitoring device and methods |
| US20140054171A1 (en) | 2012-02-21 | 2014-02-27 | Abbott Diabetes Care Inc. | Analyte Sensor Utilizing Oxygen as Oxidant |
| US9535027B2 (en) | 2012-07-25 | 2017-01-03 | Abbott Diabetes Care Inc. | Analyte sensors and methods of using same |
| US9743871B2 (en) | 2012-09-24 | 2017-08-29 | Dexcom, Inc. | Multiple electrode system for a continuous analyte sensor, and related methods |
| US8920628B2 (en) | 2012-11-02 | 2014-12-30 | Roche Diagnostics Operations, Inc. | Systems and methods for multiple analyte analysis |
| US8921061B2 (en) * | 2012-11-02 | 2014-12-30 | Roche Diagnostics Operations, Inc. | Reagent materials and associated test elements |
| US9344777B2 (en) | 2012-12-20 | 2016-05-17 | Abbott Diabetes Care Inc. | Wireless communication authentication for medical monitoring device |
| JP2014160024A (ja) | 2013-02-20 | 2014-09-04 | Jnc Corp | 酵素修飾電極、該酵素修飾電極の製造方法、およびこれを用いた電気化学反応装置、並びにそれを用いた化学物質の製造方法 |
| US9487811B2 (en) | 2013-03-15 | 2016-11-08 | Abbott Point Of Care Inc. | Biosensor structures for improved point of care testing and methods of manufacture thereof |
| US9562874B2 (en) | 2013-03-15 | 2017-02-07 | Abbott Point Of Care Inc. | Biosensor with improved interference characteristics |
| EP3087771B1 (en) | 2013-12-27 | 2020-06-17 | Abbott Diabetes Care, Inc. | Systems, devices, and methods for authentication in an analyte monitoring environment |
| EP2927319A1 (en) | 2014-03-31 | 2015-10-07 | Roche Diagnostics GmbH | High load enzyme immobilization by crosslinking |
| US20170121754A1 (en) | 2014-06-20 | 2017-05-04 | Abbott Diabetes Care Inc. | Test Strip, Meter, and Method for Assaying Enzyme Activity |
| WO2016025064A1 (en) | 2014-08-15 | 2016-02-18 | Abbott Diabetes Care Inc. | Temperature insensitive in vivo analyte devices, methods and systems |
| BR112017001444B1 (pt) | 2014-08-25 | 2022-08-16 | F. Hoffmann-La Roche Ag | Método para detectar pelo menos um analito em uma amostra de teste, elemento sensor, dispositivo de teste, sistema de teste, uso do elemento sensor e portador de dados |
| JP6584821B2 (ja) | 2015-04-30 | 2019-10-02 | 株式会社東芝 | 測定用セル、検出装置および分析装置 |
| GB201507506D0 (en) | 2015-04-30 | 2015-06-17 | Inside Biometrics Ltd | Electrochemical test device |
| GB201507508D0 (en) | 2015-04-30 | 2015-06-17 | Inside Biometrics Ltd | Electrochemical Test Device |
| US10410538B2 (en) * | 2015-05-07 | 2019-09-10 | Dexcom, Inc. | System and method for educating users, including responding to patterns |
| US10780222B2 (en) | 2015-06-03 | 2020-09-22 | Pacific Diabetes Technologies Inc | Measurement of glucose in an insulin delivery catheter by minimizing the adverse effects of insulin preservatives |
| WO2016196993A2 (en) | 2015-06-04 | 2016-12-08 | Omni Biomedical, Inc. | Multi-mediator reagent formulations for use in electrochemical detection |
| AU2016280696B2 (en) | 2015-06-15 | 2021-11-18 | Abbott Diabetes Care Inc. | Stabilized lactate responsive enzymes, electrodes and sensors, and methods for making and using the same |
| US10238346B2 (en) * | 2015-09-25 | 2019-03-26 | Sanmina Corporation | System and method for a biosensor integrated in a vehicle |
| EP3394252B1 (en) | 2015-12-21 | 2020-04-29 | F. Hoffmann-La Roche AG | Mutant 3-hydroxybutyrate dehydrogenase from alcaligenes faecalis as well as methods and uses involving the same |
| ES2782199T3 (es) | 2016-02-09 | 2020-09-11 | Hoffmann La Roche | 3-Hidroxibutirato deshidrogenasa mutante de Rhodobacter sphaeroides, así como procedimientos y usos que implican la misma |
| DK3423591T3 (da) | 2016-03-04 | 2024-01-29 | Abbott Diabetes Care Inc | NAD(P)-afhængige sensitive enzymer, elektroder og sensorer og fremgangsmåder til fremstilling og anvendelse deraf |
| US10324058B2 (en) | 2016-04-28 | 2019-06-18 | Medtronic Minimed, Inc. | In-situ chemistry stack for continuous glucose sensors |
| WO2018067878A1 (en) | 2016-10-05 | 2018-04-12 | Abbott Laboratories | Devices and methods for sample analysis |
| KR102372113B1 (ko) | 2016-10-05 | 2022-03-07 | 에프. 호프만-라 로슈 아게 | 다중 분석물 진단 테스트 엘리먼트들을 위한 검출 시약들 및 전극 배열들, 그리고 그것을 사용하는 방법들 |
| EP3531120A4 (en) | 2016-10-24 | 2020-06-10 | PHC Holdings Corporation | ELECTRON MEDIATOR OXIDIZING AGENT |
| WO2018106129A1 (en) | 2016-12-09 | 2018-06-14 | Digital Sensing Limited | Electrochemical sensors and methods of use thereof |
| EP4538692A3 (en) * | 2017-06-30 | 2025-06-18 | Abbott Diabetes Care | Method and apparatus for analyte detection using an electrochemical biosensor |
| DE202018006591U1 (de) | 2017-08-18 | 2021-07-21 | Abbott Diabetes Care, Inc. | Systeme und Vorrichtungen betreffend die individualisierte Kalibrierung und/oder Herstellung von medizinischen Vorrichtungen |
| EP3703564A1 (en) | 2017-10-30 | 2020-09-09 | Abbott Diabetes Care Inc. | Transcutaneous sensor with dual electrodes and methods of detecting and compensating for withdrawal of a transcutaneous sensor from a patient |
| US10434033B2 (en) | 2017-11-01 | 2019-10-08 | Vena Group, LLC | Portable, reusable, and disposable intermittent pneumatic compression system |
| US12076145B2 (en) | 2018-04-19 | 2024-09-03 | Abbott Diabetes Care Inc. | Lactate sensors and associated methods |
| US11744492B2 (en) | 2018-08-29 | 2023-09-05 | Medtronic, Inc. | Electrochemical sensor including multiple work electrodes and common reference electrode |
| JP2022509742A (ja) | 2018-12-07 | 2022-01-24 | バイオリンク，インク． | 生理学的流体中の循環ケトン体のレベル上昇の測定 |
| EP4552566A1 (en) | 2019-01-28 | 2025-05-14 | Abbott Diabetes Care, Inc. | Analyte sensors and sensing methods for detecting creatinine |
| CN113453620B (zh) | 2019-01-28 | 2024-03-05 | 美国雅培糖尿病护理公司 | 用于双重检测葡萄糖和乙醇的分析物传感器和感测方法 |
| EP4574038A3 (en) | 2019-01-28 | 2025-08-27 | Abbott Diabetes Care, Inc. | Analyte sensors and sensing methods featuring dual detection of glucose and ketones |
| CA3126240A1 (en) | 2019-01-28 | 2020-08-06 | Abbott Diabetes Cares Inc. | Analyte sensors employing multiple enzymes and methods associated therewith |
| EP3948249A4 (en) | 2019-03-24 | 2023-11-22 | Baldwa, Mehul | BIOSENSOR FOR DETECTING ANALYTES IN A FLUID |
| CN115038381A (zh) | 2020-01-03 | 2022-09-09 | 美国雅培糖尿病护理公司 | 用于检测多种分析物的传感器阵列系统和方法 |
-
2020
- 2020-01-28 EP EP25175406.5A patent/EP4574038A3/en active Pending
- 2020-01-28 LT LTEPPCT/US2020/015365T patent/LT3917396T/lt unknown
- 2020-01-28 FI FIEP20712075.9T patent/FI3917396T3/fi active
- 2020-01-28 WO PCT/US2020/015365 patent/WO2020159956A1/en not_active Ceased
- 2020-01-28 EP EP20712075.9A patent/EP3917396B1/en active Active
- 2020-01-28 US US16/774,835 patent/US12594013B2/en active Active
- 2020-01-28 MX MX2021008964A patent/MX2021008964A/es unknown
- 2020-01-28 AU AU2020216325A patent/AU2020216325B2/en active Active
- 2020-01-28 MY MYPI2021003154A patent/MY196781A/en unknown
- 2020-01-28 DK DK20712075.9T patent/DK3917396T3/da active
- 2020-01-28 EP EP25175392.7A patent/EP4643777A1/en active Pending
- 2020-01-28 JP JP2021538681A patent/JP7196315B2/ja active Active
- 2020-01-28 CN CN202080008102.1A patent/CN113329689A/zh active Pending
- 2020-01-28 EP EP24198176.0A patent/EP4509046A3/en active Pending
- 2020-01-28 ES ES20712075T patent/ES2995203T3/es active Active
- 2020-01-28 EP EP25175399.2A patent/EP4606303A1/en active Pending
- 2020-01-28 CA CA3123053A patent/CA3123053A1/en active Pending
-
2021
- 2021-07-26 MX MX2025009473A patent/MX2025009473A/es unknown
-
2022
- 2022-12-08 AU AU2022283734A patent/AU2022283734B2/en active Active
- 2022-12-14 JP JP2022199046A patent/JP7448621B2/ja active Active
- 2022-12-19 US US18/068,077 patent/US20230121367A1/en active Pending
- 2022-12-19 US US18/068,072 patent/US12588844B2/en active Active
- 2022-12-19 US US18/068,019 patent/US20230128038A1/en not_active Abandoned
- 2022-12-20 US US18/068,807 patent/US20230121101A1/en not_active Abandoned
- 2022-12-20 US US18/068,834 patent/US20230122702A1/en not_active Abandoned
- 2022-12-20 US US18/068,704 patent/US20230118818A1/en active Pending
- 2022-12-20 US US18/068,714 patent/US20230123384A1/en not_active Abandoned
- 2022-12-20 US US18/068,860 patent/US12594014B2/en active Active
-
2024
- 2024-02-29 JP JP2024029355A patent/JP7634121B2/ja active Active
-
2025
- 2025-02-07 JP JP2025018851A patent/JP2025069427A/ja active Pending
- 2025-05-26 AU AU2025203882A patent/AU2025203882A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2995203T3 (en) | Analyte sensors featuring dual detection of glucose and ketones | |
| ES2992515T3 (es) | Sensores de analitos que utilizan múltiples enzimas | |
| ES2999412T3 (en) | Analyte sensors and sensing methods for dual detection of glucose and ethanol | |
| ES2999057T3 (en) | Analyte sensors and sensing methods for detecting creatinine |